HRID2075446
反应详情
EQUATION
反应方程式
REACTANTS
反应物
HCID7972
4-Methylmorpholine
C5H11NO
HCID78288
Glycine, N-[(1,1-dimethylethoxy)carbonyl]-
C7H13NO4
HCID149026
Tetrafluoro-m-phenylenediamine dihydrochloride
C6H6Cl2F4N2
HCID2723939
1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride
C8H18ClN3
HCID2796029
1H-Benzotriazol-1-ol--water (1/1)
C6H7N3O2
HCID11427553
(4-((1E)-2-(1H-Indazol-3-yl)ethenyl)phenyl)-1-piperazinylmethanone
C20H20N4O
HCID21893726
Hydrochloride methanol
CH5ClO
HCID67090572
未命名化合物
PRODUCTS
生成物
PROCEDURE
实验过程
In a similar manner to Example 5, (E)-4-(tert-butoxycarbonylamino)acetyl-1-{4-[2-(1H-indazol-3-yl)vinyl]benzoyl}piperazine was obtained using dihydrochloride of Compound 18 (800 mg, 2.18 mmol), N-(tert-butoxycarbonyl)glycine (314 mg, 1.79 mmol), 1-hydroxybenzotriazole monohydrate (315 mg, 2.56 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (482 mg, 2.51 mmol) and N-methylmorpholine (0.80 mL, 7.28 mmol). In a similar manner to Example 18, (E)-4-(tert-butoxycarbonylamino)acetyl-1-{4-[2-(1H-indazol-3-yl)vinyl]benzoyl}piperazine was treated with 10% hydrogen chloride-methanol solution to obtain Compound 61 (448 mg, 64%).